A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis.

2000
https://researcherprofiles.org/profile/1419542
10751249
Goodkin DE, Shulman M, Winkelhake J, Waubant E, Andersson P, Stewart T, Nelson S, Fischbein N, Coyle PK, Frohman E, Jacobs L, Holcenberg J, Lee M, Mocci S